Overcoming Antigen Escape and T-Cell Exhaustion in CAR-T Therapy for Leukemia.

Cells · 2024 · PMC11430486 · PMID 39329777

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might be significantno p-value reported

With that, CAR-Ts were able to recognize different antigens without requiring redesign and time-consuming remanufacturing, which might be significant to the optimization of the duration of therapy.

also in 2,457 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.